more than 500 million packs of drugs are produced at the Group's 18 manufacturing sites including a biotech plant for the manufacturing of monoclonal antibodies that also serves external clients. Our drugs are distributed across 6 continents for the...
La tua nuova azienda
Our client is a global biotech company based in the United States that focuses on developing RNA interference (RNAi) therapies to treat genetic, rare, and chronic diseases.
Il tuo nuovo ruolo
In order to expand our Italian...